Nick Goldner, PhD

HOME  |  TEAM  | 

Nick Goldner, PhD

CEO & Co-Founder

Nick Goldner is a treatment resistance scientist, investor, entrepreneur, and survivor. He is dedicated to solving treatment resistance. He is the Co-Founder & CEO of resistanceBio, which focuses on developing therapies for treatment-resistant cancer. He received his Ph.D. from Washington University in St. Louis, where he focused on understanding and overcoming treatment resistance mechanisms to novel and approved compounds. Beyond resistanceBio, Nick is a venture partner for Pioneer Fund and invests in the broader biotech, diagnostic, and digital healthcare space. 

Email: Nick Goldner